Egerton Capital (uk) Llp buys $343.7 Million stake in DaVita HealthCare Partners Inc (DVA)

DaVita HealthCare Partners Inc (DVA) : Egerton Capital (uk) Llp scooped up 933 additional shares in DaVita HealthCare Partners Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 4,557,487 shares of DaVita HealthCare Partners Inc which is valued at $343.7 Million.DaVita HealthCare Partners Inc makes up approximately 3.26% of Egerton Capital (uk) Llp’s portfolio.

Other Hedge Funds, Including , Cipher Capital Lp sold out all of its stake in DVA during the most recent quarter. The investment firm sold 58,129 shares of DVA which is valued $4.4 Million.Cls Investments boosted its stake in DVA in the latest quarter, The investment management firm added 1,512 additional shares and now holds a total of 8,890 shares of DaVita HealthCare Partners Inc which is valued at $670,484. DaVita HealthCare Partners Inc makes up approx 0.03% of Cls Investments’s portfolio.Davidson Garrard Inc reduced its stake in DVA by selling 11,861 shares or 38.25% in the most recent quarter. The Hedge Fund company now holds 19,152 shares of DVA which is valued at $1.4 Million. DaVita HealthCare Partners Inc makes up approx 0.37% of Davidson Garrard Inc’s portfolio. Timber Hill sold out all of its stake in DVA during the most recent quarter. The investment firm sold 12,826 shares of DVA which is valued $970,928.Huntington National Bank boosted its stake in DVA in the latest quarter, The investment management firm added 83 additional shares and now holds a total of 293 shares of DaVita HealthCare Partners Inc which is valued at $21,653.

DaVita HealthCare Partners Inc opened for trading at $75.4 and hit $77.13 on the upside on Monday, eventually ending the session at $77.07, with a gain of 2.19% or 1.65 points. The heightened volatility saw the trading volume jump to 12,55,056 shares. Company has a market cap of $15,915 M.

On the company’s financial health, DaVita HealthCare Partners Inc reported $0.92 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.87. The company had revenue of $3581.00 million for the quarter, compared to analysts expectations of $3495.91 million. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.86 EPS.

Many Wall Street Analysts have commented on DaVita HealthCare Partners Inc. Shares were Reiterated by RBC Capital Mkts on Feb 16, 2016 to “Sector Perform” and Lowered the Price Target to $ 71 from a previous price target of $80 .

DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.

Leave a Reply

DaVita HealthCare Partners Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on DaVita HealthCare Partners Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.